Recent Studies Promote Organo Gold’s Coffee

Coffee is one of the most popular drinks in the world. Also, many companies such as Organo Gold supply the product in over 50 countries. While people naturally enjoy coffee, the beverage is much more beneficial than just a convenient drink. Health benefits of coffee have been subject of discussion for long. Two recent studies cemented the health and possible life elongating benefits of the drink.

Veronica W. Setiawan, an associate professor at the University of Southern California, co-authored a study in the “Annals of Internal Medicine.” The publication was a culmination of over 16 years of research on 185,000 Americans. The study sought to find out the association between coffee drinking and some diseases such as cancer, stroke, diabetes, and kidney diseases among others. The study incorporated all races available in America. The study concluded that coffee drinkers are less likely to die from the mentioned diseases, unlike non-coffee drinkers who are vulnerable to the diseases. The overall effect is that coffee drinkers live 18% longer than non-coffee drinkers.
Another study about coffee published in “Annals of Internal Medicine,” was done in Europe. The European study surveyed over 520,000 residents of ten different countries. According to the European study, people who regularly partake in coffee tend to live longer than those who abstained from the beverage.
The two studies reinforce what Organo Gold has been popularizing since it was founded in 2008. The company markets premium coffee which contains Ganoderma lucidum which has many health benefits on the human bodies. In addition, the company sells tea products which are equally beneficial to people. As the enterprise is interested in health and wellness, it also offers weight management products among other useful products.
Organo Gold is a network company available in over 50 countries, and the brand is currently expanding.

Leave a Reply

Your email address will not be published. Required fields are marked *


Hi, guest!